Terns Pharmaceuticals to Present at Upcoming Investor Conferences

Terns Pharmaceuticals, Inc., a biopharmaceutical company focused on developing best-in-class single-agent and combination therapies to treat liver disease, today announced that the Companys management team will present at two upcoming investor conferences.